Mandate

Vinge advised Hemfosa Fastigheter AB in connection with the acquisition of the Landic VIII portfolio

February 03, 2011

Vinge has advised Hemfosa Fastigheter AB in connection with the acquisition of the Landic VIII portfolio for approximately SEK 2.2 billion. The portfolio consists of 57 properties spread over 42 locations in Sweden. Almost 80 per cent of the rental income emanates from public authorities. Several of the properties have a market value of between SEK 5-40 million, although the portfolio also includes large properties such as the premises occupied by the Swedish Migration Board in Norrköping (Presidenten 1), the municipal council building in Haninge (Söderbymalm 3:486) and Sollentuna police station (Transporten 2). The portfolio comprises a total of 300,000 sq. m. and most of the lettable area consists of office space.

Vinge’s team consisted of partner Patrick Forslund and associates Niclas Winnberg and Daniel Unger.

Related

Vinge advises Axcel and Sanviva on the acquisitions of DermaCura and YourRad

Vinge has advised Axcel Elevate I and Sanviva in connection with the acquisitions of DermaCura and YourRad.
September 07, 2026

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026

Vinge advises the sellers on the sale of Nextory to Bonnier Books

Vinge has acted as legal adviser to the sellers in connection with Bonnier Books’ acquisition of Nextory, one of Europe’s leading streaming services for audiobooks and e-books. Bonnier Books is acquiring all shares in Nextory, and the transaction comprises Nextory’s operations in Sweden and internationally. The acquisition is a cash transaction and the parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals.
September 02, 2026